LSE · AZN.L
AstraZeneca PLC
£130.52+£2.88 (+2.26%)
AstraZeneca PLC’s quoted price sits in the upper half of its reported 52-week range, 17.04% below the high.
Loading market information…
LSE · MPAL.L · GBp
Stock price, earnings
Quote as of Oct 29, 2026, 04:28 PM UTC. Cached market data; not a live quote.
One-year closing-price history · GBp. Historical prices are not a forecast.
MedPal AI Plc’s quoted price sits in the lower half of its reported 52-week range, 41.76% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow MedPal AI Plc’s reporting calendar.
THE COMPANY BEHIND THE TICKER
MedPal AI PLC operates as a digital health and artificial intelligence company focused on wellness management in United Kingdom. The company's application aggregates data from wearable fitness trackers or health apps, such as Apple Health, Google Fit, Whoop, Fitbit, and Garmin into a unified health profile, enabling personalized lifestyle recommendations through its AI wellness coach, as well as operates as a non-clinical wellness facilitator. MedPal AI PLC was incorporated in 2021 and is based in London, United Kingdom.
Latest available per-share figures in GBp. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
£130.52+£2.88 (+2.26%)
AstraZeneca PLC’s quoted price sits in the upper half of its reported 52-week range, 17.04% below the high.
£18.14-£0.18 (-0.96%)
GSK plc’s quoted price sits in the lower half of its reported 52-week range, 20.51% below the high.
£3.18-£0.56 (-15.05%)
Haleon plc’s quoted price sits in the lower half of its reported 52-week range, 26.73% below the high.
$37.52+$0.41 (+1.1%)
Roivant Sciences Ltd.’s quoted price sits in the upper half of its reported 52-week range, 11.72% below the high.
£11.21+£0.02 (+0.13%)
Smith & Nephew plc’s quoted price sits in the lower half of its reported 52-week range, 21.42% below the high.
$97.56+$2.38 (+2.5%)
Kiniksa Pharmaceuticals International, plc’s quoted price sits in the upper half of its reported 52-week range, 0.81% below the high.
£2.43-£0.01 (-0.33%)
ConvaTec Group Plc’s quoted price sits in the upper half of its reported 52-week range, 6.21% below the high.
£17.24+£0.02 (+0.12%)
Hikma Pharmaceuticals PLC’s quoted price sits in the upper half of its reported 52-week range, 7.56% below the high.
